However, because data on the mutation rate of the c-kit gene and the genotypic profile in colonic GIST are also limited, it remains unknown whether or not colonic GIST is as sensitive as stomach and small bowel GISTs to imatinib. This evidence concerns the gene KIT and gastrointestinal stromal tumor.